Registry Cohort Study to Determine Risk for Multiple Sclerosis After Vaccination for Pandemic Influenza A(H1N1) With Arepanrix, Manitoba, Canada
Emerging Infectious Diseases - United States
doi 10.3201/eid2407.161783
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Centers for Disease Control and Prevention (CDC)